Cyclacel Pharmaceuticals Inc

NASDAQ:CYCC   3:59:53 PM EDT
1.23
+0.02 (+1.65%)
Earnings Announcements

Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/28/2022 20:25 GMT
Cyclacel Pharmaceuticals Inc (CYCC) - Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results.
Cyclacel Pharmaceuticals Inc - Estimates That Available Cash Resources Will Fund Currently Planned Programs Through Mid-2023.
Cyclacel Pharmaceuticals Inc - Net Loss for Three Months Ended December 31, 2021 Was $5.3 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.